InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.75
(
0.00%
)
US TECH 100
18,294.80
(
-0.13%
)
Dow Jones
38,931.86
(
-0.35%
)
Brent Oil
83.26
(
0.50%
)
Bitcoin
67,533.95
(
-2.66%
)
Post# of 1153
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

cash2go

Send PM Follow Ignore
Followers 16
Posts 4589
Boards Moderated 0
Alias Born 07/15/2002

cash2go

Re: surf1944 post# 285

Wednesday, 03/09/2011 11:02:09 PM

Wednesday, March 09, 2011 11:02:09 PM

Post# of 1153
BARDA-CBRN-BAA-11-100-SOL-00009

Announcement Type and Date: Initial Announcement, March 4, 2009. Renewal Announcement March 4, 2011


page 8

Area of Interest #2: Antitoxins and Therapeutics

2.3 Development of monoclonal anthrax antitoxins including non-clinical, completion of a phase 1 trial; development of a phase 2 clinical development, manufacture at pilot scale under GMP; process development and scale up including fill-finish.
2.4 Development of novel formulations of monoclonal anthrax antitoxins.

https://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=89ba389b4424e98020cb3de547001825&_cview=0
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up